Literature DB >> 12789323

Signal transduction: A regulator branches out.

Alain Israël.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12789323     DOI: 10.1038/423596a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.

Authors:  May Daher; Juliana Elisa Hidalgo Lopez; Jasleen K Randhawa; Kausar Jabeen Jabbar; Yue Wei; Naveen Pemmaraju; Gautam Borthakur; Tapan Kadia; Marina Konopleva; Hagop M Kantarjian; Katherine Hearn; Zeev Estrov; Steven Reyes; Carlos E Bueso-Ramos; Guillermo Garcia-Manero
Journal:  Am J Hematol       Date:  2017-06-09       Impact factor: 10.047

2.  Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.

Authors:  Giuseppina Bonizzi; Magali Bebien; Dennis C Otero; Kirsten E Johnson-Vroom; Yixue Cao; Don Vu; Anil G Jegga; Bruce J Aronow; Gourisankar Ghosh; Robert C Rickert; Michael Karin
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

Review 3.  Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?

Authors:  Yiwei Li; Dejuan Kong; Aamir Ahmad; Bin Bao; Fazlul H Sarkar
Journal:  Antioxid Redox Signal       Date:  2013-03-14       Impact factor: 8.401

4.  Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model.

Authors:  Jianfeng Liu; Xin Gu; Delira Robbins; Guohong Li; Runhua Shi; Joe M McCord; Yunfeng Zhao
Journal:  PLoS One       Date:  2009-04-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.